MSB 7.69% $1.19 mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-306

  1. 1,402 Posts.
    lightbulb Created with Sketch. 345
    I was thinking the same thing, this week would be ideal to release a positive ann on the MIS-C kids compassionate program!

    Go Mesoblast!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.